What are the challenges of translating positive trial results in severe sepsis into clinical practice? A media roundtable debate, 18 March 2002, Brussels, Belgium

被引:2
作者
Ball, J [1 ]
机构
[1] Univ London St Georges Hosp, Sch Med, Dept Anaesthesia & Intens Care, London SW17 0RE, England
关键词
health resources; sepsis;
D O I
10.1186/cc1503
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The clinical syndrome of sepsis is common, increasing in incidence and responsible for as many deaths annually as ischaemic heart disease. Two recent interventional trials have demonstrated that early recognition and intervention can result in dramatic reductions in acute (28-day) mortality. This roundtable discussion was convened to identify ways in which these recent advances could be translated into clinical practice. The first obstacle surrounds the woolly and confusing terminology surrounding 'sepsis' with the systemic inflammatory response syndrome (SIRS) model largely discredited. Overcoming this should facilitate wider recognition, not only among health care providers (in particular those working in acute specialties outside intensive care units [ICUs]) but also politicians and the general public. Such education is vital if early recognition and intervention are to be successfully implemented.
引用
收藏
页码:271 / 274
页数:4
相关论文
共 17 条
[1]   Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation [J].
Abraham, E ;
Matthay, MA ;
Dinarello, CA ;
Vincent, JL ;
Cohen, J ;
Opal, SM ;
Glauser, M ;
Parsons, P ;
Fisher, CJ ;
Repine, JE .
CRITICAL CARE MEDICINE, 2000, 28 (01) :232-235
[2]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[3]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[4]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[5]   Multiple organ dysfunction: Baseline and serial component scores [J].
Cook, R ;
Cook, D ;
Tilley, J ;
Lee, KA ;
Marshall, J .
CRITICAL CARE MEDICINE, 2001, 29 (11) :2046-2050
[6]   Epidemiological differences between sepsis syndrome with bacteremia and culture-negative sepsis [J].
Fariñas-Alvarez, C ;
Fariñas, MC ;
Fernández-Mazarrasa, C ;
Llorca, J ;
Delgado-Rodríguez, M .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (10) :639-644
[7]   Randomized, controlled clinical trials in sepsis: Has methodological quality improved over time? [J].
Graf, J ;
Doig, GS ;
Cook, DJ ;
Vincent, JL ;
Sibbald, WJ .
CRITICAL CARE MEDICINE, 2002, 30 (02) :461-472
[8]   Definition of sepsis [J].
Matot, I ;
Sprung, CL .
INTENSIVE CARE MEDICINE, 2001, 27 (Suppl 1) :S3-S9
[9]  
Opal S M, 2001, Curr Opin Crit Care, V7, P347, DOI 10.1097/00075198-200110000-00006
[10]   Early goal-directed therapy in the treatment of severe sepsis and septic shock. [J].
Rivers, E ;
Nguyen, B ;
Havstad, S ;
Ressler, J ;
Muzzin, A ;
Knoblich, B ;
Peterson, E ;
Tomlanovich, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) :1368-1377